InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tenaya Therapeutics, Inc.

TNYA Clue Score23
United States Fiscal year ends December CIK 0001858848 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
David Goeddel V
5 Mar 2025
Director
Buy indirect
35,714,284
$0.70
$25.00M
Column Group III Gp, LP
5 Mar 2025
10% owner
Buy indirect
35,714,284
$0.70
$25.00M
David Goeddel V
12 Feb 2024
Director
Buy indirect
2,222,222
$4.50
$10.00M
Column Group III Gp, LP
12 Feb 2024
10% owner
Buy indirect
2,222,222
$4.50
$10.00M
David Goeddel V
10 Mar 2023
Director
Buy indirect
6,779
$2.60
$17.60K
Column Group III Gp, LP
10 Mar 2023
10% owner
Buy indirect
6,779
$2.60
$17.60K
David Goeddel V
8 Feb 2023
Director
Buy indirect
1,500,000
$2.60
$3.90M
Column Group III Gp, LP
8 Feb 2023
10% owner
Buy indirect
1,500,000
$2.60
$3.90M
David Goeddel V
19 Jan 2023
Director
Buy indirect
69,739
$2.50
$174.20K
Column Group III Gp, LP
19 Jan 2023
10% owner
Buy indirect
69,739
$2.50
$174.20K
David Goeddel V
18 Jan 2023
Director
Buy indirect
135,688
$2.52
$341.43K
Column Group III Gp, LP
18 Jan 2023
10% owner
Buy indirect
135,688
$2.52
$341.43K
David Goeddel V
17 Jan 2023
Director
Buy indirect
49,463
$2.49
$123.40K
Column Group III Gp, LP
17 Jan 2023
10% owner
Buy indirect
49,463
$2.49
$123.40K
David Goeddel V
21 Nov 2022
Director
Buy indirect
9,615,384
$2.60
$25.00M
Column Group III Gp, LP
21 Nov 2022
10% owner
Buy indirect
9,615,384
$2.60
$25.00M
Deepak Srivastava
21 Nov 2022
Director
Buy indirect
230,769
$2.60
$600.00K
Eli Casdin
17 Nov 2022
Director
Buy indirect
2,492,042
$2.60
$6.48M
Eli Casdin
3 Aug 2021
Director
Buy indirect
850,000
$15.00
$12.75M
Casdin Partners Master Fund, L.P.
3 Aug 2021
10% owner
Buy indirect
850,000
$15.00
$12.75M
Show all 96 transactions →

What was left out

Form 4 filings counted 124
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 0
Sales at will 72
Transactions with no price 0
Shares from compensation/vesting 25,322,084
Sales filed before the plan box existed 1
History held since 4 Aug 2021